Eli Lilly has forged a major partnership with Profluent to develop advanced gene-editing tools using artificial intelligence, aiming to address... Read more
Category: Uncategorized
Merck and Remepy form alliance to pioneer hybrid drug development
Merck KGaA has entered into a collaborative agreement with Remepy to develop integrated "hybrid drugs" that merge pharmacological treatments with... Read more
Gilead finalizes $7.8 billion purchase of Arcellx
Gilead Sciences has concluded its merger with Arcellx, a move designed to secure full rights to an investigational cell therapy... Read more
Cellares and Cabaletta Bio ink 10-year pact to automate cell therapy manufacturing
A milestone in automated autologous CAR-T production Cellares and Cabaletta Bio have formalized a 10-year commercial supply agreement, marking a... Read more
Kite Pharma optimizes manufacturing ahead of next-generation cell therapy approval
Leveraging operational insights to accelerate commercialization Following an initial phase of navigating capacity constraints and logistical hurdles in the CAR-T... Read more
Proposal for a centralized management model in food safety
Establishing a seamless management structure from central to local levels The Ministry of Health is currently leading the development of... Read more
Update on legal policies and market fluctuations on April 29
Adjusting the legal framework for sub-standard goods The police authorities are currently seeking opinions to amend criminal regulations. A key... Read more
BD and Suttons Creek partner to streamline combination product development
Becton, Dickinson and Company (BD) and Suttons Creek have entered into a strategic collaboration to assist pharmaceutical and biotech firms... Read more
Thermo Fisher Scientific opens flagship U.S. Bioprocess Design Center in Massachusetts
Thermo Fisher Scientific Inc. has inaugurated its flagship U.S. Bioprocess Design Center (BDC) at its Plainville, Massachusetts site. This expansion... Read more









